1
|
Roston TM, Hart A, Krahn AD, Sanatani S. The challenge of implantable cardioverter-defibrillator programming and shock interpretation in treatment-refractory catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Med (Hagerstown) 2019; 20:569-571. [DOI: 10.2459/jcm.0000000000000814] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
2
|
Bögeholz N, Willy K, Niehues P, Rath B, Dechering DG, Frommeyer G, Kochhäuser S, Löher A, Köbe J, Reinke F, Eckardt L. Spotlight on S-ICD™ therapy: 10 years of clinical experience and innovation. Europace 2019; 21:1001-1012. [DOI: 10.1093/europace/euz029] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2018] [Accepted: 02/09/2019] [Indexed: 11/14/2022] Open
Abstract
Abstract
Subcutaneous ICD (S-ICD™) therapy has been established in initial clinical trials and current international guideline recommendations for patients without demand for pacing, cardiac resynchronization, or antitachycardia pacing. The promising experience in ‘ideal’ S-ICD™ candidates increasingly encourages physicians to provide the benefits of S-ICD™ therapy to patients in clinical constellations beyond ‘classical’ indications of S-ICD™ therapy, which has led to a broadening of S-ICD™ indications in many centres. However, the decision for S-ICD™ implantation is still not covered by controlled randomized trials but rather relies on patient series or observational studies. Thus, this review intends to give a contemporary update on available empirical evidence data and technical advancements of S-ICD™ technology and sheds a spotlight on S-ICD™ therapy in recently discovered fields of indication beyond ideal preconditions. We discuss the eligibility for S-ICD™ therapy in Brugada syndrome as an example for an adverse and dynamic electrocardiographic pattern that challenges the S-ICD™ sensing and detection algorithms. Besides, the S-ICD™ performance and defibrillation efficacy in conditions of adverse structural remodelling as exemplified for hypertrophic cardiomyopathy is discussed. In addition, we review recent data on potential device interactions between S-ICD™ systems and other implantable cardio-active systems (e.g. pacemakers) including specific recommendations, how these could be prevented. Finally, we evaluate limitations of S-ICD™ therapy in adverse patient constitutions, like distinct obesity, and present contemporary strategies to assure proper S-ICD™ performance in these patients. Overall, the S-ICD™ performance is promising even for many patients, who may not be ‘classical’ candidates for this technology.
Collapse
Affiliation(s)
- Nils Bögeholz
- Division of Electrophysiology, Department of Cardiology and Angiology, University Hospital of Muenster, Muenster, Germany
| | - Kevin Willy
- Division of Electrophysiology, Department of Cardiology and Angiology, University Hospital of Muenster, Muenster, Germany
| | - Philipp Niehues
- Division of Electrophysiology, Department of Cardiology and Angiology, University Hospital of Muenster, Muenster, Germany
| | - Benjamin Rath
- Division of Electrophysiology, Department of Cardiology and Angiology, University Hospital of Muenster, Muenster, Germany
| | - Dirk G Dechering
- Division of Electrophysiology, Department of Cardiology and Angiology, University Hospital of Muenster, Muenster, Germany
| | - Gerrit Frommeyer
- Division of Electrophysiology, Department of Cardiology and Angiology, University Hospital of Muenster, Muenster, Germany
| | - Simon Kochhäuser
- Division of Electrophysiology, Department of Cardiology and Angiology, University Hospital of Muenster, Muenster, Germany
| | - Andreas Löher
- Department of Cardiothoracic Surgery, University Hospital of Muenster, Muenster, Germany
| | - Julia Köbe
- Division of Electrophysiology, Department of Cardiology and Angiology, University Hospital of Muenster, Muenster, Germany
| | - Florian Reinke
- Division of Electrophysiology, Department of Cardiology and Angiology, University Hospital of Muenster, Muenster, Germany
| | - Lars Eckardt
- Division of Electrophysiology, Department of Cardiology and Angiology, University Hospital of Muenster, Muenster, Germany
| |
Collapse
|
3
|
Al-Ghamdi B. Subcutaneous Implantable Cardioverter Defibrillators: An Overview of Implantation Techniques and Clinical Outcomes. Curr Cardiol Rev 2019; 15:38-48. [PMID: 30014805 PMCID: PMC6367695 DOI: 10.2174/1573403x14666180716164740] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/12/2018] [Revised: 07/09/2018] [Accepted: 07/10/2018] [Indexed: 11/22/2022] Open
Abstract
Sudden Cardiac Death (SCD) is a significant health problem worldwide. Multiple randomized controlled trials have shown that Implantable Cardioverter Defibrillators (ICDs) are effective life-saving management option for individuals at risk of SCD in both primary and secondary prevention. Although the conventional transvenous ICDs (TV-ICDs) are safe and effective, there are potential complications associated with its use, including localized pocket or wound infection or systematic infection, a vascular access related complication such as pneumothorax, and venous thrombosis, and lead related complications such as dislodgement, malfunction, and perforation. Furthermore, transvenous leads placement may not be feasible in certain patients like those with venous anomaly or occlusion, or with the presence of intracardiac shunts. Transvenous leads extraction, when needed, is associated with considerable morbidity & mortality and requires significant skills and costs. Totally subcutaneous ICD (S-ICD) is designed to afford the same life-saving benefit of the conventional TV-ICDs while avoiding the shortcomings of the TV-leads and to simplify the implant techniques and hence expand the use of ICDs in clinical practice. It becomes commercially available after receiving CE mark in 2009, and its use increased significantly after its FDA approval in 2012. This review aims to give an overview of the S-ICD system components, implantation procedure, clinical indications, safety, efficacy, and future directions.
Collapse
Affiliation(s)
- Bandar Al-Ghamdi
- Heart Center, College of Medicine, King Faisal Specialist Hospital & Research Centre, Zahrawi St, Al Maather, Riyadh 12713, Saudi Arabia.,Alfaisal University, College of Medicine, King Faisal Specialist Hospital & Research Centre, Zahrawi St, Al Maather, Riyadh 12713, Saudi Arabia
| |
Collapse
|
4
|
Sieira J, Ciconte G, Conte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, Saitoh Y, Casado-Arroyo R, Juliá J, La Meir M, Wellens F, Wauters K, Pappaert G, Brugada P. Long-term prognosis of drug-induced Brugada syndrome. Heart Rhythm 2017; 14:1427-1433. [DOI: 10.1016/j.hrthm.2017.04.044] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/23/2016] [Indexed: 11/25/2022]
|
5
|
Kawabata M, Goya M, Sasaki T, Maeda S, Yagishita A, Shirai Y, Kaneko M, Shiohira S, Isobe M, Hirao K. Surface Electrocardiogram Screening for Subcutaneous Implantable Cardioverter-Defibrillators in Japanese Patients With and Without Brugada Syndrome. Circ J 2017; 81:981-987. [DOI: 10.1253/circj.cj-16-1295] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
| | - Masahiko Goya
- Heart Rhythm Center, Tokyo Medical and Dental University
| | - Takeshi Sasaki
- Heart Rhythm Center, Tokyo Medical and Dental University
| | - Shingo Maeda
- Heart Rhythm Center, Tokyo Medical and Dental University
| | | | | | | | | | - Mitsuaki Isobe
- Department of Cardiovascular Medicine, Tokyo Medical and Dental University
| | - Kenzo Hirao
- Heart Rhythm Center, Tokyo Medical and Dental University
| |
Collapse
|
6
|
Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience. J Clin Anesth 2016; 31:53-9. [DOI: 10.1016/j.jclinane.2015.11.009] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2014] [Revised: 09/03/2015] [Accepted: 11/12/2015] [Indexed: 11/19/2022]
|
7
|
Sieira J, Conte G, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, Saitoh Y, Irfan G, Casado-Arroyo R, Juliá J, La Meir M, Wellens F, Wauters K, Pappaert G, Brugada P. Clinical characterisation and long-term prognosis of women with Brugada syndrome. Heart 2016; 102:452-8. [PMID: 26740482 DOI: 10.1136/heartjnl-2015-308556] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/18/2015] [Accepted: 12/10/2015] [Indexed: 11/03/2022] Open
Abstract
OBJECTIVES Brugada syndrome (BS) in women is considered an infrequent condition with a more favourable prognosis than in men. Nevertheless, arrhythmic events and sudden cardiac death (SCD) also occur in this population. Long-term follow-up data of this group are sparse. The purpose of the present study was to investigate the clinical characteristics and long-term prognosis of women with BS. METHODS A consecutive cohort of 228 women presenting with spontaneous or drug-induced Brugada type I ECG at our institution were included and compared with 314 men with the same diagnosis. RESULTS Mean age was 41.5±17.3 years. Clinical presentation was SCD in 6 (2.6%), syncope in 51 (22.4%) and the remaining 171 (75.0%) were asymptomatic. As compared with men, spontaneous type I ECG was less common (7.9% vs 23.2%, p<0.01) and less ventricular arrhythmias were induced during programmed electrical stimulation (5.5% vs 22.3%, p<0.01). An implantable cardioverter defibrillator (ICD) was implanted in 64 women (28.1%). During a mean follow-up of 73.2±56.2 months, seven patients developed arrhythmic events, constituting an event rate of 0.7% per year (as compared with 1.9% per year in men, p=0.02). Presentation as SCD or sinus node dysfunction (SND) was risk factor significantly associated with arrhythmic events (hazard risk (HR) 25.4 and 9.1). CONCLUSION BS is common in women, representing 42% of patients in our database. Clinical presentation is less severe than men, with more asymptomatic status and less spontaneous type I ECG and prognosis is more favourable, with an event rate of 0.7% year. However, women with SCD or previous SND are at higher risk of arrhythmic events.
Collapse
Affiliation(s)
- Juan Sieira
- Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium
| | - Giulio Conte
- Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium
| | - Giuseppe Ciconte
- Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium
| | | | | | | | | | - Yukio Saitoh
- Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium
| | - Ghazala Irfan
- Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium
| | | | - Justo Juliá
- Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium
| | - Mark La Meir
- Cardiac Surgery Department, UZ Brussel-VUB, Brussels, Belgium
| | - Francis Wellens
- Cardiac Surgery Department, UZ Brussel-VUB, Brussels, Belgium
| | - Kristel Wauters
- Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium
| | - Gudrun Pappaert
- Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium
| | - Pedro Brugada
- Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium
| |
Collapse
|
8
|
Sieira J, Ciconte G, Conte G, Chierchia GB, de Asmundis C, Baltogiannis G, Di Giovanni G, Saitoh Y, Irfan G, Casado-Arroyo R, Julià J, La Meir M, Wellens F, Wauters K, Pappaert G, Brugada P. Asymptomatic Brugada Syndrome: Clinical Characterization and Long-Term Prognosis. Circ Arrhythm Electrophysiol 2015. [PMID: 26215662 DOI: 10.1161/circep.114.003044] [Citation(s) in RCA: 64] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Among Brugada syndrome patients, asymptomatic individuals are considered to be at the lowest risk. Nevertheless, arrhythmic events and sudden cardiac death are not negligible. Literature focused on this specific group of patients is sparse. The purpose of this study is to investigate the clinical characteristics, management, and long-term prognosis of asymptomatic Brugada syndrome patients. METHODS AND RESULTS Patients presenting with spontaneous or drug-induced Brugada type I ECG and no symptoms at our institution were considered eligible. A total of 363 consecutive patients (200 men, 55.1%; mean age, 40.9±17.2 years; 41 [11.3%] with spontaneous type I ECG) were included. Electrophysiological study was performed in 321 (88.4%) patients, and ventricular arrhythmias were induced in 32 (10%) patients. An implantable cardioverter defibrillator was implanted in 61 (16.8%) patients. After a mean follow-up time of 73.2±58.9 months, 9 arrhythmic events occurred, accounting for an annual incidence rate of 0.5%. Event-free survival was 99.0% at 1 year, 96.2% at 5 years, and 95.4% at 10 and 15 years. Univariate analysis identified as risk factors: electrophysiological study inducibility (hazard ratio, 11.4; P<0.01), spontaneous type I (hazard ratio, 4.0; P=0.04), and previous sinus node dysfunction (hazard ratio, 8.0; 95% confidence interval, 1.0-63.9; P=0.05). At the multivariate analysis, only inducibility remained significant (hazard ratio, 9.1; P<0.01). CONCLUSIONS Arrhythmic events in asymptomatic Brugada syndrome patients are not insignificant. Ventricular arrhythmia inducibility, spontaneous type I ECG, and presence of sinus node dysfunction might be considered as risk factors and used to drive long-term management.
Collapse
Affiliation(s)
- Juan Sieira
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.).
| | - Giuseppe Ciconte
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Giulio Conte
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Gian-Battista Chierchia
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Carlo de Asmundis
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Giannis Baltogiannis
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Giacomo Di Giovanni
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Yukio Saitoh
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Ghazala Irfan
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Rubén Casado-Arroyo
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Justo Julià
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Mark La Meir
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Francis Wellens
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Kristel Wauters
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Gudrun Pappaert
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| | - Pedro Brugada
- From the Heart Rhythm Management Centre (J.S., G. Ciconte, G. Conte, G.-B.C., C.d.A., G.B., G.D.G., Y.S., G.I., J.J., K.W., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital, Brussels, Belgium (R.C.-A.)
| |
Collapse
|
9
|
Sieira J, Conte G, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, Saitoh Y, Irfan G, Casado-Arroyo R, Juliá J, La Meir M, Wellens F, Wauters K, Van Malderen S, Pappaert G, Brugada P. Prognostic value of programmed electrical stimulation in Brugada syndrome: 20 years experience. Circ Arrhythm Electrophysiol 2015; 8:777-84. [PMID: 25904495 DOI: 10.1161/circep.114.002647] [Citation(s) in RCA: 82] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/29/2014] [Accepted: 04/10/2015] [Indexed: 11/16/2022]
Abstract
BACKGROUND The prognostic value of electrophysiological investigations in individuals with Brugada syndrome remains controversial. Different groups have published contradictory data. Long-term follow-up is needed to clarify this issue. METHODS AND RESULTS Patients presenting with spontaneous or drug-induced Brugada type I ECG and in whom programmed electric stimulation was performed at our institution were considered eligible for this study. A total of 403 consecutive patients (235 males, 58.2%; mean age, 43.2±16.2 years) were included. Ventricular arrhythmias during programmed electric stimulation were induced in 73 (18.1%) patients. After a mean follow-up time of 74.3±57.3 months (median 57.3), 25 arrhythmic events occurred (16 in the inducible group and 9 in the noninducible). Ventricular arrhythmias inducibility presented a hazard ratio for events of 8.3 (95% confidence interval, 3.6-19.4), P<0.01. CONCLUSIONS Programmed ventricular stimulation of the heart is a good predictor of outcome in individuals with Brugada syndrome. It might be of special value to guide further management when performed in asymptomatic individuals. The overall accuracy of the test makes it a suitable screening tool to reassure noninducible asymptomatic individuals.
Collapse
Affiliation(s)
- Juan Sieira
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.).
| | - Giulio Conte
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Giuseppe Ciconte
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Carlo de Asmundis
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Gian-Battista Chierchia
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Giannis Baltogiannis
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Giacomo Di Giovanni
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Yukio Saitoh
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Ghazala Irfan
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Ruben Casado-Arroyo
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Justo Juliá
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Mark La Meir
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Francis Wellens
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Kristel Wauters
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Sophie Van Malderen
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Gudrun Pappaert
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| | - Pedro Brugada
- From the Heart Rhythm Management Centre (J.S., G. Conte, G. Ciconte, C.d.A., G.-B.C., G.B., G.D.G., Y.S., G.I., J.J., K.W., S.V.M., G.P., P.B.) and Cardiac Surgery Department (M.L.M., F.W.), UZ Brussel-VUB, Brussels, Belgium; and Department of Cardiology, Erasme University Hospital-ULB, Brussels, Belgium (R.C.-A.)
| |
Collapse
|
10
|
Conte G, Sieira J, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, La Meir M, Wellens F, Czapla J, Wauters K, Levinstein M, Saitoh Y, Irfan G, Julià J, Pappaert G, Brugada P. Implantable Cardioverter-Defibrillator Therapy in Brugada Syndrome. J Am Coll Cardiol 2015; 65:879-88. [DOI: 10.1016/j.jacc.2014.12.031] [Citation(s) in RCA: 140] [Impact Index Per Article: 15.6] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/03/2014] [Revised: 12/07/2014] [Accepted: 12/12/2014] [Indexed: 12/11/2022]
|
11
|
De Maria E, Cappelli S, Cappato R. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome. Heart Rhythm 2013; 10:1807-9. [DOI: 10.1016/j.hrthm.2013.08.008] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/11/2013] [Indexed: 10/26/2022]
|
12
|
Current World Literature. Curr Opin Cardiol 2009; 24:95-101. [DOI: 10.1097/hco.0b013e32831fb366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|